No, GLP-1 receptor agonists are not FDA-approved for treating alcohol use disorder or reducing alcohol cravings
Who Each Medication Might Suit Patient Profiles Tirzepatide Good Fit If You Want: A well-studied, clinically proven option Steady, predictable fat loss and metabolic support An accessible medication now (current approval and availability) Balanced results with moderate side-effect profile Retatrutide May Be Ideal If You Want: A next-generation therapy with stronger fat-loss potential Deeper metabolic shift and body-composition changes A more aggressive approach and are open to an investigational therapy with close supervision The possibility of enhanced energy expenditure and fat oxidation beyond appetite suppression At Everest, we believe the right choice depends on your goals, health history, metabolic profile, and readiness for advanced care not on hype or trends
This hormone plays a crucial role in managing your appetite and blood sugar levels
There is no legal pathway to get a retatrutide prescription anywhere in the world right now
Retatrutide is a triple-action medication that targets three receptors involved in appetite regulation and metabolism
Food and Drug Administration